{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:35:00Z","timestamp":1760146500887,"version":"build-2065373602"},"reference-count":32,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Wroclaw Medical University","doi-asserted-by":"publisher","award":["SUBZ.E090.24.031."],"award-info":[{"award-number":["SUBZ.E090.24.031."]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background: SARS-CoV-2 enters cells primarily by binding to the angiotensin-converting enzyme 2 (ACE2) receptor, thereby blocking its physiological functions, affecting the apelinergic system, and inhibiting the cleavage of its peptides. The appropriate concentration of peptides in the apelinergic system influences the maintenance of homeostasis and protects against cardiovascular diseases. In our research, we determined the level of selected parameters of the apelinergic system\u2014apelin (AP), elabela (ELA), and the apelin receptor (APJ)\u2014in repeat blood donors. Methods: We analyzed 120 serum samples obtained from 30 repeat donors (study group) within four time periods after a SARS-CoV-2 infection: &lt;60 days, 61\u201390 days, 91\u2013120 days, and &gt;120 days. We compared the results from the study groups with those of the control group, which consisted of 30 serum samples collected from donors donating blood in the years 2018\u20132019. Results: We observed that the AP, ELA, and APJ concentrations in the control group are higher than in any period in the study group. In the study group, the concentrations of AP and ELA increased in subsequent study periods. AP and ELA concentrations were lower shortly after SARS-CoV-2 transfection and then slowly increased in subsequent periods. APJ concentrations, on the other hand, were lowest at 61\u201390 days after the infection, but the decrease, relative to their level in healthy subjects, was significant in every period studied. Conclusions: The results suggest that infection with SARS-CoV-2 causes changes in the parameters of the apelinergic system, both after a short period of time has passed since the onset of the SARS-CoV-2 infection, and even up to 4 months after the infection.<\/jats:p>","DOI":"10.3390\/biomedicines12112583","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T05:21:59Z","timestamp":1731388919000},"page":"2583","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of SARS-CoV-2 Infection on Selected Parameters of the Apelinergic System in Repeat Blood Donors"],"prefix":"10.3390","volume":"12","author":[{"given":"Marta","family":"Stanek","sequence":"first","affiliation":[{"name":"Regional Center of Transfusion Medicine and Blood Bank, 50-345 Wroc\u0142aw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3826-0452","authenticated-orcid":false,"given":"Anna","family":"Le\u015bk\u00f3w","sequence":"additional","affiliation":[{"name":"Division of Medical Biology, Faculty of Nursing and Midwifery, Wroclaw Medical University, 50-368 Wroc\u0142aw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1377-5601","authenticated-orcid":false,"given":"Dorota","family":"Diakowska","sequence":"additional","affiliation":[{"name":"Division of Medical Biology, Faculty of Nursing and Midwifery, Wroclaw Medical University, 50-368 Wroc\u0142aw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.23736\/S0026-4806.23.08509-9","article-title":"Role of Available COVID-19 Vaccines in Reducing Deaths and Perspective for next Generation Vaccines and Therapies to Counter Emerging Viral Variants: An Update","volume":"114","author":"Wahid","year":"2023","journal-title":"Minerva Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","article-title":"Comparing COVID-19 Vaccines for Their Characteristics, Efficacy and Effectiveness against SARS-CoV-2 and Variants of Concern: A Narrative Review","volume":"28","author":"Fiolet","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Postlethwait, J.H., Massaquoi, M.S., Farnsworth, D.R., Yan, Y.L., Guillemin, K., and Miller, A.C. (2021). The SARS-CoV-2 Receptor and Other Key Components of the Renin-Angiotensin-Aldosterone System Related to COVID-19 Are Expressed in Enterocytes in Larval Zebrafish. Biol. Open, 10.","DOI":"10.1242\/bio.058172"},{"key":"ref_4","first-page":"24","article-title":"Characterization of the Angiotensin-Converting Enzyme 2 (ACE2), the Main Receptor for the SARS-CoV-2 Virus","volume":"12","author":"Jami","year":"2023","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mehrabadi, M.E., Hemmati, R., Tashakor, A., Homaei, A., Yousefzadeh, M., Hemati, K., and Hosseinkhani, S. (2021). Induced Dysregulation of ACE2 by SARS-CoV-2 Plays a Key Role in COVID-19 Severity. Biomed. Pharmacother., 137.","DOI":"10.1016\/j.biopha.2021.111363"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Maza, M.d.C., \u00dabeda, M., Delgado, P., Horndler, L., Llamas, M.A., van Santen, H.M., Alarc\u00f3n, B., Abia, D., Garc\u00eda-Bermejo, L., and Serrano-Villar, S. (2022). ACE2 Serum Levels as Predictor of Infectability and Outcome in COVID-19. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.836516"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Yang, P., Kuc, R.E., Brame, A.L., Dyson, A., Singer, M., Glen, R.C., Cheriyan, J., Wilkinson, I.B., Davenport, A.P., and Maguire, J.J. (2017). [Pyr1]Apelin-13(1-12) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr1]Apelin-13. Front. Neurosci., 11.","DOI":"10.3389\/fnins.2017.00092"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/qjmed\/hcac229","article-title":"Apelin as a New Therapeutic Target for COVID-19 Treatment","volume":"116","author":"Park","year":"2023","journal-title":"QJM Int. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2020.06.007","article-title":"Apelin-Potential Therapy for COVID-19?","volume":"145","author":"Beer","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wyderka, R., Diakowska, D., \u0141oboz-Rudnicka, M., Mercik, J., Borger, M., Osuch, \u0141., Brzezi\u0144ska, B., Le\u015bk\u00f3w, A., Krzystek-Korpacka, M., and Jaroch, J. (2023). Influence of the Apelinergic System on Conduction Disorders in Patients after Myocardial Infarction. J. Clin. Med., 12.","DOI":"10.3390\/jcm12247603"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/cphy.c170028","article-title":"Apelinergic System Structure and Function","volume":"8","author":"Shin","year":"2017","journal-title":"Compr. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/cvr\/cvad171","article-title":"Targeting the Apelin System for the Treatment of Cardiovascular Diseases","volume":"119","author":"Chapman","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5336\/pharmsci.2020-76153","article-title":"Vascular Functional Effects of the Apelinergic System","volume":"10","author":"Demirel","year":"2021","journal-title":"J. Lit. Pharm. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2021.05.029","article-title":"Abnormal Apelin-ACE2 and SGLT2 Signaling Contribute to Adverse Cardiorenal Injury in Patients with COVID-19","volume":"336","author":"Li","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.53730\/ijhs.v6nS6.10990","article-title":"Comparative Study of Apelin and Glucose Levels in COVID-19 Patients","volume":"6","author":"Kenoosh","year":"2022","journal-title":"Int. J. Health Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s40001-022-00852-3","article-title":"Changes in Serum Levels of Apelin and Nitric Oxide in Hospitalized Patients with COVID-19: Association with Hypertension, Diabetes, Obesity, and Severity of Disease","volume":"27","author":"Rostamzadeh","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.32007\/jfacmedbagdad.6431928","article-title":"Measurement of the Serum Level of Elabela for the Early Detection of Acute Kidney Injury in Hospitalized Iraqi COVID-19 Patients","volume":"64","author":"Gadhi","year":"2022","journal-title":"J. Fac. Med. Baghdad"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Van Den Hurk, K., Zalpuri, S., Prinsze, F.J., Merz, E.M., and De Kort, W.L.A.M. (2017). Associations of Health Status with Subsequent Blood Donor Behavior\u2014An Alternative Perspective on the Healthy Donor Effect from Donor InSight. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186662"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e48617","DOI":"10.2196\/48617","article-title":"Exploration of the Healthy Donor Effect Among 0.6 Million Blood Donors in China: Longitudinal Study","volume":"10","author":"Su","year":"2024","journal-title":"JMIR Public Health Surveill."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/trf.17190","article-title":"The Healthy Donor Effect and Survey Participation, Becoming a Donor and Donor Career","volume":"63","author":"Brodersen","year":"2023","journal-title":"Transfusion"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5603\/ahp.99505","article-title":"Evaluation of Serological and Hematological Parameters in Donors of SARS-CoV-2 Convalescent Plasma of Respect to Time Periods of Donation","volume":"55","author":"Stanek","year":"2024","journal-title":"Acta Haematol. Pol."},{"key":"ref_22","unstructured":"(2024, August 19). Rozporz\u0105dzenie Ministra Zdrowia w Sprawie Warunk\u00f3w Pobierania Krwi Od Kandydat\u00f3w Na Dawc\u00f3w Krwi i Dawc\u00f3w Krwi; Dziennik Ustaw Rzeczypospolitej Polskiej poz. 1741: Polska, Available online: https:\/\/isap.sejm.gov.pl\/isap.nsf\/DocDetails.xsp?id=WDU20170001741."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/CM9.0000000000001766","article-title":"Targeting the Elabela\/Apelin-Apelin Receptor Axis as a Novel Therapeutic Approach for Hypertension","volume":"135","author":"Song","year":"2022","journal-title":"Chin. Med. J."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Wang, Z., Yu, D., Wang, M., Wang, Q., Kouznetsova, J., Yang, R., Qian, K., Wu, W., Shuldiner, A., and Sztalryd, C. (2015). Elabela-Apelin Receptor Signaling Pathway Is Functional in Mammalian Systems. Sci. Rep., 5.","DOI":"10.1038\/srep08170"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s40200-022-01088-y","article-title":"Recent Advances in Molecular Biology of Metabolic Syndrome Pathophysiology: Endothelial Dysfunction as a Potential Therapeutic Target","volume":"21","author":"Marzoog","year":"2022","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41392-021-00822-x","article-title":"COVID-19 Induces New-Onset Insulin Resistance and Lipid Metabolic Dysregulation via Regulation of Secreted Metabolic Factors","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e28494","DOI":"10.1002\/jmv.28494","article-title":"Efficacy of Serum Apelin and Galectin-3 as Potential Predictors of Mortality in Severe COVID-19 Patients","volume":"95","author":"Berber","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1164\/rccm.202101-0142LE","article-title":"ACE2 Elevation in Severe COVID-19","volume":"203","author":"Eskandary","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1089\/can.2022.0018","article-title":"Cannabinoids as Emergent Therapy Against COVID-19","volume":"7","author":"Mcgrail","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","article-title":"Elabela\/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension","volume":"135","author":"Yang","year":"2017","journal-title":"Circulation"},{"key":"ref_32","first-page":"11180","article-title":"Evaluation of Elabela, Visfatin, and Chemerin Levels as Inflammation Biomarkers in COVID-19","volume":"27","author":"Mermutluoglu","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/11\/2583\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:30:30Z","timestamp":1760113830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/11\/2583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["biomedicines12112583"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines12112583","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2024,11,12]]}}}